Citius Oncology (NASDAQ:CTOR) Cut to Hold at Maxim Group
Maxim Group downgraded shares of Citius Oncology (NASDAQ:CTOR – Free Report) from a strong-buy rating to a hold rating in a report issued on Friday morning, Marketbeat.com reports. Citius Oncology Price Performance CTOR stock opened at $0.91 on Friday. The business has a fifty day moving average price of $0.76 and a 200 day moving […]
Maxim Group downgraded shares of Citius Oncology (NASDAQ:CTOR – Free Report) from a strong-buy rating to a hold rating in a report issued on Friday morning, Marketbeat.com reports. Citius Oncology Price Performance CTOR stock opened at $0.91 on Friday. The business has a fifty day moving average price of $0.76 and a 200 day moving […]
